Tutorials
Achilles Therapeutics PLC logo

Achilles Therapeutics PLC

$ 3.03 -0.07 (-2.26%) 11:08 AM EST
P/E:
At Loss
P/B:
0.46
Market Cap:
$ 123.54M
Enterprise V:
$ -98.53M
Volume:
12.39K
Avg Vol (2M):
45.72K
Also Trade In:
Volume:
12.39K
Market Cap $:
123.54M
PE Ratio:
At Loss
Avg Vol (2-Month):
45.72K
Enterprise Value $:
-98.53M
PB Ratio:
0.46
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Achilles Therapeutics PLC
245 Hammersmith Road, London, GBR, W6 8PW
Description
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing novel cancer immunotherapies targeting clonal neoantigens. The company has two ongoing trials, the CHIRON trial in patients with advanced non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.
Name Current Vs Industry Vs History
Cash-To-Debt 19.94
Equity-to-Asset 0.91
Debt-to-Equity 0.05
Debt-to-EBITDA -0.18
Interest Coverage N/A
N/A
N/A
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 93.13
9-Day RSI 82.4
14-Day RSI 74.08
6-1 Month Momentum % -22.44
12-1 Month Momentum % -56.11

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 14.51
Quick Ratio 14.51
Cash Ratio 13.27

Dividend & Buy Back

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2022-08-10 Est.)

ACHL's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:ACHL

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -1.68
Beta 0
Volatility % 52.11
14-Day RSI 74.08
14-Day ATR ($) 0.168475
20-Day SMA ($) 2.6325
12-1 Month Momentum % -56.11
52-Week Range ($) 1.84 - 11.4
Shares Outstanding (Mil) 40.77

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Achilles Therapeutics PLC Filings

Document Form Filing Date
No Filing Data

Headlines

See More